Lucas Nivon ๐Ÿ‡บ๐Ÿ‡ธ (@lucas_nivon) 's Twitter Profile
Lucas Nivon ๐Ÿ‡บ๐Ÿ‡ธ

@lucas_nivon

@[email protected] CEO and Co-Founder at Cyrus Bio. Computational protein/biologic drug discovery. Auto-immune disease.

ID: 1309059890

linkhttp://cyrusbio.com calendar_today28-03-2013 01:11:42

540 Tweet

504 Followers

568 Following

Rosetta Commons (@rosettacommons) 's Twitter Profile Photo

News from the Rosetta community: Prosculpt โ€“ an open-source library integrating RFDiffusion, ProteinMPNN, AlphaFold2 & Rosetta into one easy workflow More via Ajasja ๐Ÿ’ป๐Ÿงฌ๐Ÿ”ฌ: rosettacommons.org/2025/05/28/allโ€ฆ

News from the Rosetta community: Prosculpt โ€“ an open-source library integrating RFDiffusion, ProteinMPNN, AlphaFold2 & Rosetta into one easy workflow

More via <a href="/AjasjaLjubetic/">Ajasja ๐Ÿ’ป๐Ÿงฌ๐Ÿ”ฌ</a>: rosettacommons.org/2025/05/28/allโ€ฆ
Lucas Nivon ๐Ÿ‡บ๐Ÿ‡ธ (@lucas_nivon) 's Twitter Profile Photo

Advancing Drug Discovery with Rosetta Pocket Protocols and Boltz-2: Finding and Modeling Druggable Binding Sites levitate.bio/boltz/ai/ml/roโ€ฆ

Lucas Nivon ๐Ÿ‡บ๐Ÿ‡ธ (@lucas_nivon) 's Twitter Profile Photo

From David Baker's lab, design of binders to intrinsically disordered proteins (IDP), with a very high success rate, 49/43 with only two dozen tested per target. Easier than for structured proteins now?? science.org/doi/10.1126/scโ€ฆ

Lucas Nivon ๐Ÿ‡บ๐Ÿ‡ธ (@lucas_nivon) 's Twitter Profile Photo

I'll be doing a (virtual) talk for BIO Asia about Cyrus's internal MHC II data platform HIDES and #ai model HIDES AI, and our partnership and founding of openfold and a sneak peak at early OpenFold3 results showing protein/ligand co-folding accuracy rivaling AF3

King Lab (@kinglabipd) 's Twitter Profile Photo

๐Ÿšจ new paper alert ๐Ÿšจ We present a method for designing protein nanoparticles with two unique faces that can bring together distinct biological targets at controlled distances! This project was led by Dr. Sanela Rankovic is out now in Nature Materials: tinyurl.com/yj8t476d

Lucas Nivon ๐Ÿ‡บ๐Ÿ‡ธ (@lucas_nivon) 's Twitter Profile Photo

Looking for a real world tutorial in using a suite of #ai #bioai tools to design antibodies with high developability using a chimeric design strategy? Terrific detailed walk-through from levitate.bio levitate.bio/antibody/tcr/cโ€ฆ

Martin Pacesa (@martinpacesa) 's Twitter Profile Photo

Exciting to see our protein binder design pipeline BindCraft published in its final form in nature ! This has been an amazing collaborative effort with Lennart, Christian Schellhaas, Sergey Ovchinnikov, Bruno Correia and many other amazing lab members and collaborators. nature.com/articles/s4158โ€ฆ